BioNTech to acquire Novartis’ Marburg manufacturing plant to expand production of COVID-19 vaccine candidates

BioNTech to acquire Novartis’ Marburg manufacturing plant to expand production of COVID-19 vaccine candidates

Biopharmaceutical New Technologies (BioNTech) has agreed to acquire a GMP certified manufacturing facility in Marburg, Germany from Novartis to expand the production capacity of its BNT162 COVID-19 vaccine candidates. The financial terms of the deal were not revealed by the parties. BioNTech said that the production capacity of its five mRNA COVID-19 vaccine candidates under […]

BNT162 COVID-19 vaccine candidate : US govt signs $2bn supply deal with Pfizer and BioNTech

BNT162 COVID-19 vaccine candidate : US govt signs $2bn supply deal with Pfizer and BioNTech

Pfizer and BioNTech have bagged a $1.95 billion deal with the US government for supplying 100 million doses of their jointly developed BNT162 COVID-19 vaccine candidate. Recently, the two pharma companies were granted the fast track designation from the US Food and Drug Administration (FDA) for BNT162b1 and BNT162b1 vaccines, which are two of the […]

BNT162b1 and BNT162b2 Covid-19 vaccine candidates get FDA fast track status

BNT162b1 and BNT162b2 Covid-19 vaccine candidates get FDA fast track status

Pfizer and BioNTech said that BNT162b1 and BNT162b2, two vaccine candidates developed to give protection against the SARS-CoV-2 virus have been given the fast track designation from the USFood and Drug Administration (FDA). The two vaccine candidates are part of the four investigational vaccine candidates that are being jointly developed by the companies under their […]

BioNTech and Pfizer forge $425m partnership to develop mRNA-based flu vaccines

BioNTech and Pfizer forge $425m partnership to develop mRNA-based flu vaccines

In a significant advancement in vaccine research, German biotech firm BioNTech has partnered with American pharmaceutical giant Pfizer in a multi-year research and development collaboration valued at $425 million. This strategic alliance is set to revolutionize influenza (flu) prevention with the development of mRNA-based flu vaccines. Under the collaboration, BioNTech and Pfizer will jointly conduct […]